Programme 2020 | EASD

You are here

Programme at a Glance - 56th EASD Annual Meeting

Tuesday, 22 September 2020

	Vienna Hall	Linz Hall	Graz Hall	Salzburg Hall	Innsbruck Hall	Klagenfurt Hall	Wels Hall
08:40 08:45	Opening #EASD2020
08:45 09:15	Presidential Address
09:15 10:00	52nd Claude Bernard Lecture
10:15 11:45	OP 1	OP 2	OP 3	OP 4	OP 5	OP 6
12:00 13:00	Poster Event A						EASD e-Learning: GLP-1 receptor agonists (12:15 - 13:15)
13:15 14:15	Poster Event B						EASD e-Learning: GLP-1 receptor agonists (12:15 - 13:15)
14:30 16:00	OP 7	OP 8	OP 9	OP 10	OP 11	OP 12
16:15 17:15	35th Camillo Golgi Lecture	14th Albert Renold Lecture 16:55 - 17:55
17:15 17:55		14th Albert Renold Lecture 16:55 - 17:55
18:10 19:10						EASD General Assembly Agenda Minutes Electronic Resolution 30 June 2020

Wednesday, 23 September 2020

	Vienna Hall	Linz Hall	Graz Hall	Salzburg Hall	Innsbruck Hall	Klagenfurt Hall	Wels Hall
08:30 10:00	EASD/ADA Symposium: ADA/EASD Precision medicine in diabetes initiative	EASD/ESC Symposium: The dawn of CV risk reduction in type 2 diabetes: 5 years of SGLT2i CV outcome trials	Sweet pregnancy	Human islet transcriptomes to gain insight into diabetes: promises and pitfalls	The LIBERATES Trial	Covid-19 and diabetes
10:15 11:45	OP 13	OP 14	OP 15	OP 16	OP 17	OP 18
12:00 13:00	Poster Event C						EASD e-Learning: Islet cell transplantation (12:15 - 13:15)
13:15 14:15	Poster Event D						EUDF Symposium: Digital health: Hope for diabetes in an uncertain and changing world? (14:00- 16:00)
14:30 16:00	OP 19	OP 20	OP 21	OP 22	OP 23	OP 24
16:15 17:15	EASD-Novo Nordisk Foundation Diabetes Prize for Excellence
17:30 18:30	What is the future of type 1 diabetes treatment?	Diabetes in primary care	VERTIS CV outcome	Diabetes and cancer	Multi-dimensional roles of ketone bodies in fuel metabolism, signalling, and therapeutics	An easy to digest guide to precision nutrition

Thursday, 24 September 2020

	Vienna Hall	Linz Hall	Graz Hall	Salzburg Hall	Innsbruck Hall	Klagenfurt Hall	Wels Hall
08:30 10:00	Diabetologia Symposium 2020: The pancreas in health and in diabetes	Advances in the pathogenesis and treatment of diabetic complications: going beyond the usual	The important conversation between the heart and the kidney	We are what we do not eat	Rising Star Symposium 08:20 - 10:00	Empagliflozin for chronic heart failure and a reduced ejection fraction in patients with and without diabetes: primary results of the EMPEROR-Reduced trial
10:15 11:45	OP 25	OP 26	OP 27	OP 28	OP 29	OP 30
12:00 13:00	Poster Event E						EASD e-Learning: Therapeutic inertia (12:15 - 13:15)
13:15 14:15	Poster Event F						EFSD Mentorship Programme (14:00 - 14:30)
14:30 16:00	OP 31	OP 32	OP 33	OP 34	OP 35	OP 36
16:15 17:00	Induction of Honorary Members 55th Minkowski Lecture
17:15 18:15	Do we need surveillance of the liver of type 2 diabetes patients?	New approaches to reducing hypoglycaemia: hype or hope	When your medicine gives you diabetes	New lessons about diabetic complications: 30 years and counting in the DCCT/EDIC	Closing the loop: commercial systems or open source?	DAPA-CKD trial

Friday, 25 September 2020

	Vienna Hall	Linz Hall	Graz Hall	Salzburg Hall	Innsbruck Hall	Klagenfurt Hall
08:30 09:30	Comprehensive approaches with novel biomarkers for predicting purposes	EASD/JDRF Symposium: Human iPSC-derived cells, the state-of-the-art to model diabetes	Targeting the gut to treat diabetes	Uric acid: a biomarker or risk factor for disease - the answer is here!	The role of altered lipid handling in diabetes	Michael Berger Debate: ESC vs EASD/ADA-guidelines on diabetes and cardiovascular disease: Same evidence but different interpretations - who’s right?
09:45 10:45	OP 37	OP 38	OP 39	OP 40	OP 41	OP 42
11:00 12:00	OP 43	OP 44	OP 45	OP 46	OP 47	OP 48
12:15 13:45	Diabetes on the run: insulin therapy in type 1 diabetes and exercise	Innovative medicines initiative (IMI): the power of public private partnerships in diabetes research	Assessing the true burden of hypoglycaemia	A gender-sensitive approach pays off in diabetes	EASD/AASD Symposium: Implementation science in diabetes	Semaglutide for the treatment of obesity (STEP-programme) 12:15 - 13:15

Programme may be subject to change.

Non-commercial satellite symposia on the occasion of the 56th EASD Annual Meeting:

Monday, 21 Sept 2020	IDF Europe Symposium: The future of diabetes nursing in Europe 14:30 - 15:30, Villach Hall
Tuesday, 22 Sept 2020	Novel biomarkers for type 2 diabetes 07:30 - 08:30, Villach Hall
	Navigating through the Covid-19 pandemic and new lessons from cardiovascular outcome trials 10:30 - 12:00, Villach Hall
	New aspects of insulin resistance 12:30 - 14:00, Villach Hall
	A disease state approach to the pharmacological management of type 2 diabetes in primary care: A position statement by PCDE 14:30 - 15:30, Villach Hall
Wednesday, 23 Sept 2020	IHSG Symposium: The clinical impact of hypoglycaemia (with expert discussion) 08:00 - 09:30, Villach Hall
	Diabetes in COVID-19 era: A challenge and opportunity for people with diabetes’ education 10:00 - 11:30, Villach Hall
	NAFLD: from mechanism to treatment 12:00 - 13:30, Villach Hall
	Diabetic Pregnancy Study Group (DPSG) Symposium 14:00 - 15:30, Villach Hall
	Mathematical metabolic modelling - towards intrinsic prediction of risk of developing insulin resistance and diabetic vascular complications 16:00 - 17:00, Villach Hall
Thursday, 24 Sept 2020	NEURODIAB Symposium 10:00 - 11:30, Villach Hall
	Exercise and Physical Activity Study Group (ExPAS) Symposium 12:00 - 13:00, Villach Hall
	Celebrating 25 years of advancement in research and practice in the psychosocial aspects of diabetes 14:00 - 15:30, Villach Hall

View the Industry Symposia Programme here